ITF Therapeutics Announces Publication of Positive Long-Term Data Reinforcing Givinostat Efficacy and Safety as a Treatment for Duchenne Muscular Dystrophy
— New data published in Annals of Clinical and Translational Neurology show that long-term treatment with givinostat can significantly delay loss of key mobility functions in patients with Duchenne muscular dystrophy — Meaningful clinical benefit was observed across treatment groups, regardless of disease stage at initiation — Givinostat remained well-tolerated during extended use, consistent with […]